Aurora Spine Corporation (TSXV:ASG) announced today that it will be will be presenting at the 15th Annual ISSAS Conference in San Diego, CA April 15-17, 2015 at Booth 411.

"Aurora Spine is please to present the Screwless Procedure(TM) product portfolio this year at the ISSAS Conference," said Trent J. Northcutt, Aurora Spine's President and CEO. "We also look forward to meeting the many talented surgeons and distributors that will be attending ISSAS. This year we are proud to showcase several FDA cleared products and procedures, all designed to improve spine patient outcomes, drive continued surgeon interests, and provide unique benefits that deliver value to hospitals and patients," said Northcutt.

Aurora Spine will display its complete range of minimally invasive spine implants, including the ZIP(TM) MIS Interspinous Fusion systems, and its Interbody portfolio featuring TiNano®. TiNano is Aurora Spine's titanium plasma spray coating on PEEK interbody cages allowing for the possibility of bone ongrowth due to its porous structure.

Aurora will also be presenting two new and exciting MIS products: the ZIP 51(TM) and the ZIP LP(TM), each developed as an alternative to pedicle screw fixation. The ZIP LP is Aurora Spine's slimmest minimally invasive interspinous fixation implant.

"Aurora is also excited to present our new Compass 4D(TM) retractor system," said Northcutt. "The enhanced features of the Compass 4D retractor will provide surgeons with the maximum amount of access to the patient's spine in a safe and reproducible minimally tissue disruptive procedure."

About Aurora Spine

Aurora Spine is an early stage company focused on bringing new solutions to the spinal implant market through a series of screwless, innovative, minimally invasive, regenerative spinal implant technologies. Aurora Spine recently obtained its 5th FDA clearance in the past 12 months and continues to position itself at the forefront of spinal surgery procedures, focusing on minimally invasive spine surgery technologies. Aurora Spine is changing spine surgery by focusing on disruptive technologies following the Company's commitment to - Simplifying the Complex.

Forward-Looking Statements

This news release contains forward-looking information that involves substantial known and unknown risks and uncertainties, most of which are beyond the control of Aurora Spine, including, without limitation, those listed under "Risk Factors" and "Cautionary Statement Regarding Forward-Looking Information" in Aurora Spine's final prospectus (collectively, "forward-looking information"). Forward-looking information in this news release includes information concerning the proposed use and success of the company's products in surgical procedures. Aurora Spine cautions investors of Aurora Spine's securities about important factors that could cause Aurora Spine's actual results to differ materially from those projected in any forward-looking statements included in this news release. Any statements that express, or involve discussions as to, expectations, beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking and may involve estimates, assumptions and uncertainties which could cause actual results or outcomes to differ unilaterally from those expressed in such forward-looking statements. No assurance can be given that the expectations set out herein will prove to be correct and, accordingly, prospective investors should not place undue reliance on these forward looking statements. These statements speak only as of the date of this press release and Aurora Spine does not assume any obligation to update or revise them to reflect new events or circumstances.

For more information, please contact:

Aurora Spine Corporation

Trent Northcutt

President and Chief Executive Officer

(760) 424-2004

Eric Fronk

Chief Financial Officer

(760) 424-2004

Christian Flores